Wednesday, 4 December 2024
  
Login

Australia's most trusted
source of pharma news

Wednesday, 04 December 2024
News

Which drugs made the PBAC's cut?

Posted 29 November 2024 AM

Twenty-five potential PBS debutantes made it onto the PBAC's slimmed down March meeting agenda - released yesterday afternoon after a 24-hour delay - and 15 of those are yet to be TGA approved.

Out of 46 submissions carefully selected for consideration, 36 are new listings and 10 are change to listing requests. The committee will also consider four sub-committee report DUSC analyses.

To see the whole article, please login

Popular

Disruption coming to Med Affairs
$56M drug hit with first generic
Four PBS listings wrap up 2024
Biosim rushes for $72M market
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home